Cleared Traditional

HEMATACHEK

K964452 · Richmond Diagnostics, Inc. · Hematology
Feb 1997
Decision
106d
Days
Class 2
Risk

About This 510(k) Submission

K964452 is an FDA 510(k) clearance for the HEMATACHEK, a Control, Hematocrit (Class II — Special Controls, product code GLK), submitted by Richmond Diagnostics, Inc. (New Brunswick, US). The FDA issued a Cleared decision on February 20, 1997, 106 days after receiving the submission on November 6, 1996. This device falls under the Hematology review panel. Regulated under 21 CFR 864.8625.

Submission Details

510(k) Number K964452 FDA.gov
FDA Decision Cleared SESE
Date Received November 06, 1996
Decision Date February 20, 1997
Days to Decision 106 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement

Device Classification

Product Code GLK — Control, Hematocrit
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.8625

Similar Devices — GLK Control, Hematocrit

EUROTROL HEMATOCRIT CONTROL
K121467 · Eurotrol B.V. · May 2013
MEDICA EASYQC HEMATOCRIT CONTROL
K021924 · Bionostics, Inc. · Jun 2002
AALTO SCIENTIFIC MIRCO HEMATOCRIT CONTROL
K020618 · Aalto Scientific, Ltd. · May 2002
CERTAIN HCT LEVEL A & LEVEL B/CVM HCT LEVELS 1,2,3, & 4
K961807 · Ciba Corning Diagnostics Corp. · Jul 1996
MSI-HCT
K924926 · Medical Specialties, Inc. · Jan 1993
A.QC HCT LEVEL 1 AND 2
K893562 · Johnson & Johnson Professionals, Inc. · Jul 1989